CLAIM CARD
A notable tension exists within the corpus between studies reporting null effects and those suggesting benefit. By contrast, Bergqvist 2021 and Papagiannakis 2025 are in agreement on the null effect of statin use on mortality in their respective contexts. This heterogeneity highlights a critical limitation: the evidence base is dominated by indirect studies of statins, a drug class known to affect CoQ10 levels, rather than direct trials of CoQ10 or ubiquinol supplementation. European patients were followed with endpoints including major adverse cardiac events and measures of functional capacity.
Evidence grade: exploratory
Contradiction status: none
Publication: b8dee5f7-0023-4af5-bacc-446de915555a
Provenance: Derivation Web chain
Citation Support
source_1Xu 2024source_2Spiegeleer 2025source_3Shang 2024source_4Alehagen 2020source_5Phan 2020